Eurax Cream
NDC Package 69489-311-60

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Eurax (crotamiton) cream is a medication used to treat scabies. This formulation utilizes a cream delivery system. Marketed by Journey Medical Corporation, this product is identified by NDC 69489-311 and is authorized under FDA application NDA006927.

Identification & Billing

NDC Package Code
69489-311-60
Package Description
1 TUBE in 1 CARTON / 60 g in 1 TUBE
Product Code
69489-311
11-Digit Billing Format
69489031160
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Eurax
Non-Proprietary Name
Crotamiton
Substance Name
Crotamiton
Dosage Form
Cream - An emulsion, semisolid3 dosage form, usually containing > 20% water and volatiles5 and/or < 50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
CROTAMITON 100 mg/g
Usage Information
This medication is used to treat scabies. Scabies is a skin infection caused by mites that burrow into the skin. Irritation from the mites leads to severe itching and small bumps/blisters filled with fluid/pus. Crotamiton works by killing the mites that cause scabies. It also helps relieve itching related to scabies and other skin conditions. Crotamiton belongs to two classes of drugs: scabicides and antipruritics.

Regulatory & Marketing

Labeler Name
Journey Medical Corporation
Product Type
Human Prescription Drug
FDA Application #
NDA006927
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
03-16-2026
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 69489-311-60 identifies a specific commercial package of 1 tube in 1 carton / 60 g in 1 tube of Eurax, a human prescription drug labeled by Journey Medical Corporation. This cream is formulated for topical use and contains crotamiton as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Journey Medical Corporation on March 16, 2026. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is used to treat scabies. Scabies is a skin infection caused by mites that burrow into the skin. Irritation from the mites leads to severe itching and small bumps/blisters filled with fluid/pus. Crotamiton works by killing the mites that cause scabies. It also helps relieve itching related to scabies and other skin conditions. Crotamiton belongs to two classes of drugs: scabicides and antipruritics.

How is this Journey Medical Corporation product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 69489031160. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
69489-311-60
11-Digit CMS (5-4-2)
69489-0311-60

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.